Peptide directorySkin, immune & repair

Granulysin

The cytotoxic T cell’s antibiotic, delivered into infected cells alongside perforin.

Where it comes from

Made in
Cytotoxic T cells and natural killer cells, stored in their granules with perforin and granzymes
Sent out by
When the killer cell meets an infected or malignant target
Acts on
  • Bacteria (including tuberculosis), fungi and parasites inside cells
  • Tumour cells
  • Keratinocytes in drug reactions

What it does

  • Kills intracellular microbes, including tuberculosis bacteria, once perforin lets it into the cell 3
  • Kills the target cell too, by damaging its mitochondria
  • The 15-kDa form is a signal that activates monocytes rather than a toxin 2

In medicine

  • The main executioner in Stevens-Johnson syndrome and toxic epidermal necrolysis: blister fluid is full of it, and blood granulysin is a research marker 1
  • Nothing is treated through it; what is studied is whether the measurement can tell those reactions from a harmless drug rash early enough to matter 1

Beyond the body’s own use

  • Engineered fragments are tested as antibiotics and as anticancer agents in the laboratory; none is in a trial
  • Mice have no granulysin gene, so every question about it has to be asked in human cells or in mice given the human one; that is the main reason it is less developed than perforin or the granzymes 2

Sources

  1. Chung et al., Granulysin is a key mediator of keratinocyte death in Stevens-Johnson syndrome, Nature Medicine 2008
  2. Krensky & Clayberger, Biology and clinical relevance of granulysin, Tissue Antigens 2009
  3. Stenger et al., An antimicrobial activity of cytolytic T cells mediated by granulysin, Science 1998

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.